Related Experiment Video
Updated: Apr 18, 2026

08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
5.2K
Bcl6 inhibits osteoclastogenesis by upregulating STAT1 phosphorylation
Xinyuan Ma1,2,3, Shuige Chen1,2,3, Yuetong Chen1,2,4
1Department of Orthodontics, School of Medicine, Tianjin Stomatological Hospital, Nankai University, Tianjin, 300041, China.
Molecular Biology Reports
|April 16, 2026
Summary
Bcl6 and STAT1 regulate osteoclast differentiation. Bcl6 overexpression and STAT1 inhibition suppress osteoclast formation, crucial for orthodontic tooth movement.
Area of Science:
- Cell Biology
- Molecular Biology
- Orthodontics
Background:
- Orthodontic tooth movement (OTM) duration depends on bone remodeling, involving osteoclast-mediated bone resorption.
- Bcl6 and STAT1 are key regulators in osteoclast differentiation.
- Understanding their interaction is vital for controlling OTM.
Purpose of the Study:
- To investigate the interaction between Bcl6 and STAT1 in regulating osteoclast differentiation.
- To determine the role of Bcl6 and STAT1 in the context of orthodontic tooth movement.
Main Methods:
- RAW264.7 cells were induced to differentiate into osteoclasts using RANKL and M-CSF.
- Cells were treated with Fludarabine (STAT1 inhibitor) or transfected with Bcl6 overexpression plasmids.
- Osteoclast differentiation, STAT1 expression, and phosphorylation were assessed via TRAP staining, RT-qPCR, and Western blot.
Main Results:
- Fludarabine treatment promoted STAT1 phosphorylation, suppressing osteoclast differentiation.
- Bcl6 overexpression enhanced STAT1 phosphorylation and inhibited osteoclast differentiation.
- Combined Bcl6 overexpression and Fludarabine treatment showed an augmented anti-osteoclastogenic effect.
Conclusions:
- Osteoclast differentiation is suppressed by Bcl6-mediated STAT1 phosphorylation.
- This mechanism offers potential targets for modulating orthodontic tooth movement duration.
Related Concept Videos
The JAK-STAT Signaling Pathway
14.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
14.2K
Osteoclasts in Bone Remodeling
4.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Receptor Downregulation in MVBs
3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
3.0K
TGF - β Signaling Pathway
11.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Hormones and Bone Tissue
4.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.3K
The Intrinsic Apoptotic Pathway
9.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K

